scholarly journals Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors

2016 ◽  
Vol 22 (14) ◽  
pp. 3560-3570 ◽  
Author(s):  
Andrea Muscat ◽  
Dean Popovski ◽  
W. Samantha N. Jayasekara ◽  
Fernando J. Rossello ◽  
Melissa Ferguson ◽  
...  
Keyword(s):  
Tumor Growth ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Low Dose ◽  
Growth Arrest ◽  
Lineage Differentiation ◽  
Deacetylase Inhibitor ◽  
Rhabdoid Tumors ◽  
Inhibitor Treatment

scholarly journals Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis

Surgery ◽  
2014 ◽  
Vol 156 (2) ◽  
pp. 214-220 ◽  
Author(s):  
Ting Zhao ◽  
Yongqing Li ◽  
Baoling Liu ◽  
Erxi Wu ◽  
Martin Sillesen ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Murine Model ◽  
Histone Deacetylase Inhibitor ◽  
Deacetylase Inhibitor ◽  
Inhibitor Treatment

scholarly journals The Histone Deacetylase Inhibitor, Vorinostat, Reduces Tumor Growth at the Metastatic Bone Site and Associated Osteolysis, but Promotes Normal Bone Loss

2010 ◽  
Vol 9 (12) ◽  
pp. 3210-3220 ◽  
Author(s):  
Jitesh Pratap ◽  
Jacqueline Akech ◽  
John J. Wixted ◽  
Gabriela Szabo ◽  
Sadiq Hussain ◽  
...  
Keyword(s):  
Bone Loss ◽  
Tumor Growth ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Normal Bone ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document